Sixian Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sixian Hu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chunchao Xia
Department of Radiology, West China Hospital of Sichuan University, Chengdu, China
2 shared publications Chuan Tian
West China Hospital, Sichuan University
1 shared publicationKeling Liu
West China Hospital, Sichuan University
1 shared publication- Lanqing Yang
Radiology Department of West China Hospital Sichuan University, Guoxue Xiang Chengdu Sichuan P. R. China
1 shared publication Ting Luo
West China Hospital, Sichuan University/West China School of Nursing, Sichuan University
1 shared publicationWanlin Peng
West China Hospital, Sichuan University
1 shared publication
Latest Publications
- Open Access
- 2 December 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (23) , e041036
Altitude‐Related Differences in Biventricular Remodeling and the Clinical Profile of Pulmonary Hypertension: An Exploratory Cardiovascular Magnetic Resonance Study
Background: Residence at high altitudes (HAs) may increase cardiovascular risk due to hypobaric hypoxia, but its synergy with pulmonary hypertension cause is unclear. This study compared clinical profile and biventricular remodeling in patients with pulmonary hypertension at HA and low altitude, and explored associate risk factors. Methods: A total of 137 patients with pulmonary hypertension who underwent cardiovascular magnetic resonance imaging were categorized into the HA (altitude ≥2500 m) and low altitude groups based on their zip code. Multiple linear regression was used to identify risk factors for ventricular remodeling. Results: The HA group showed higher hemoglobin, liver enzyme, and γ‐glutamyl transpeptidase levels. Accordingly, the left ventricular ejection fraction in the HA group was reduced (50.91±10.13% versus 58.10±7.84%, P =0.001), whereas the left ventricular volume was enlarged (all P P< 0.05), and reduced biventricular longitudinal peak strain (right ventricle: −11.48±4.25% versus −13.26±2.75%, P= 0.001; left ventricle: −11.24±3.65% versus −13.42±2.83%, P= 0.018). Multiple linear regression analyses revealed that the γ‐glutamyl transpeptidase level was associated with deteriorated biventricular function (left ventricular ejection fraction, B=−0.06; right ventricular ejection fraction, B=−0.110; all P< 0.05), whereas the hemoglobin level was associated with the left ventricular longitudinal peak strain (B=0.599; P< 0.05), particularly among HA residents. Conclusions: HA residence was linked to more severe biventricular remodeling in patients with pulmonary hypertension, particularly in the left ventricle. Higher γ‐glutamyl transpeptidase levels were independently associated with biventricular remodeling parameters.
- 2 December 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (23) , e041036
Open AccessAltitude‐Related Differences in Biventricular Remodeling and the Clinical Profile of Pulmonary Hypertension: An Exploratory Cardiovascular Magnetic Resonance Study
Background: Residence at high altitudes (HAs) may increase cardiovascular risk due to hypobaric hypoxia, but its synergy with pulmonary hypertension cause is unclear. This study compared clinical profile and biventricular remodeling in patients with pulmonary hypertension at HA and low altitude, and explored associate risk factors. Methods: A total of 137 patients with pulmonary hypertension who underwent cardiovascular magnetic resonance imaging were categorized into the HA (altitude ≥2500 m) and low altitude groups based on their zip code. Multiple linear regression was used to identify risk factors for ventricular remodeling. Results: The HA group showed higher hemoglobin, liver enzyme, and γ‐glutamyl transpeptidase levels. Accordingly, the left ventricular ejection fraction in the HA group was reduced (50.91±10.13% versus 58.10±7.84%, P =0.001), whereas the left ventricular volume was enlarged (all P P< 0.05), and reduced biventricular longitudinal peak strain (right ventricle: −11.48±4.25% versus −13.26±2.75%, P= 0.001; left ventricle: −11.24±3.65% versus −13.42±2.83%, P= 0.018). Multiple linear regression analyses revealed that the γ‐glutamyl transpeptidase level was associated with deteriorated biventricular function (left ventricular ejection fraction, B=−0.06; right ventricular ejection fraction, B=−0.110; all P< 0.05), whereas the hemoglobin level was associated with the left ventricular longitudinal peak strain (B=0.599; P< 0.05), particularly among HA residents. Conclusions: HA residence was linked to more severe biventricular remodeling in patients with pulmonary hypertension, particularly in the left ventricle. Higher γ‐glutamyl transpeptidase levels were independently associated with biventricular remodeling parameters.
- 20 August 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 62 (6) , 1742-1751
Assessing the Diagnostic Value of MRI T1rho Mapping in Predicting Molecular Prognostic Biomarkers and Subtypes of Breast Cancer
Background: Prognostic factors and molecular subtypes are important in treatment planning and predicting response to therapy in breast cancer, and the exploration of noninvasive imaging methods to characterize breast cancer has been ongoing. Purpose: To evaluate the use of T1rho mapping in predicting the status of prognostic biomarkers and molecular subtypes of breast cancer. Study Type: Prospective. Subjects: Ninety One women with breast tumors. Field Strength/Sequence: 3T, T1 rho prepared balanced turbo field echo sequence. Assessment: Mean T1rho values were compared between positive and negative status of prognostic biomarkers [estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and proliferation index (Ki‐67)] and molecular subtypes. Statistical Tests: Independent t test, one‐way analysis of variance, Kruskal–Wallis test, chi‐square test, Fisher exact test, and receiver operating characteristic (ROC) analysis. Results: Mean T1rho values were significantly higher in ER‐negative compared to ER‐positive tumors (70 ± 6.769 vs. 55 ± 10.791 ms), in PR‐negative compared to PR‐positive tumors (68.48 ± 9.563 vs. 60.46 ± 10.099 ms), and in high Ki‐67 proliferation compared to low Ki‐67 proliferation tumors (66.59 ± 8.994 vs. 57.77 ± 11.501 ms). Significant negative correlations were observed between ER and PR statuses and T1rho values ( r s = 0.416 and 0.392, respectively). The Ki‐67 status was significantly positively correlated with T1rho values ( r s = 0.369). The Luminal A subtype had a significantly lower T1rho value than other subtypes (56.46 ± 10.553 vs. 66.58 ± 9.204 ms). The Luminal B subtype had significantly lower T1rho values than the triple‐negative (TN) subtype (63.957 ± 9.794 vs. 72.237 ± 8.229 ms). The TN subtype had a significantly higher T1rho value than luminal subtypes (72.237 ± 8.229 vs. 62.903 ± 10.289 ms). The T1rho values had good diagnostic performance in identifying Luminal A and TN breast cancers with areas under the ROC curve of 0.767 and 0.776. Data Conclusion: T1rho mapping has the potential to be a non‐invasive imaging biomarker for evaluating the prognostic biomarkers and molecular subtypes of breast cancer.
- 20 August 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 62 (6) , 1742-1751
Assessing the Diagnostic Value of MRI T1rho Mapping in Predicting Molecular Prognostic Biomarkers and Subtypes of Breast Cancer
Background: Prognostic factors and molecular subtypes are important in treatment planning and predicting response to therapy in breast cancer, and the exploration of noninvasive imaging methods to characterize breast cancer has been ongoing. Purpose: To evaluate the use of T1rho mapping in predicting the status of prognostic biomarkers and molecular subtypes of breast cancer. Study Type: Prospective. Subjects: Ninety One women with breast tumors. Field Strength/Sequence: 3T, T1 rho prepared balanced turbo field echo sequence. Assessment: Mean T1rho values were compared between positive and negative status of prognostic biomarkers [estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and proliferation index (Ki‐67)] and molecular subtypes. Statistical Tests: Independent t test, one‐way analysis of variance, Kruskal–Wallis test, chi‐square test, Fisher exact test, and receiver operating characteristic (ROC) analysis. Results: Mean T1rho values were significantly higher in ER‐negative compared to ER‐positive tumors (70 ± 6.769 vs. 55 ± 10.791 ms), in PR‐negative compared to PR‐positive tumors (68.48 ± 9.563 vs. 60.46 ± 10.099 ms), and in high Ki‐67 proliferation compared to low Ki‐67 proliferation tumors (66.59 ± 8.994 vs. 57.77 ± 11.501 ms). Significant negative correlations were observed between ER and PR statuses and T1rho values ( r s = 0.416 and 0.392, respectively). The Ki‐67 status was significantly positively correlated with T1rho values ( r s = 0.369). The Luminal A subtype had a significantly lower T1rho value than other subtypes (56.46 ± 10.553 vs. 66.58 ± 9.204 ms). The Luminal B subtype had significantly lower T1rho values than the triple‐negative (TN) subtype (63.957 ± 9.794 vs. 72.237 ± 8.229 ms). The TN subtype had a significantly higher T1rho value than luminal subtypes (72.237 ± 8.229 vs. 62.903 ± 10.289 ms). The T1rho values had good diagnostic performance in identifying Luminal A and TN breast cancers with areas under the ROC curve of 0.767 and 0.776. Data Conclusion: T1rho mapping has the potential to be a non‐invasive imaging biomarker for evaluating the prognostic biomarkers and molecular subtypes of breast cancer.